Development of radiopharmaceuticals to target neurotensin receptors based on 68Ga and 177Lu

被引：0
|
作者：
Niculae, Dana [1 ]
Mihon, Mirela [2 ,3 ]
Leonte, Radu [2 ,3 ]
Silisteanu, Andrei [2 ,3 ]
机构：
[1] Horia Hulubei Natl Inst Phys & Nucl Engn, Radioisotopes & Radiat Metrol, Magurele, Romania
[2] Politehn Univ, Bucharest, Romania
[3] Horia Hulubei Natl Inst Phys & Nucl Engn, Bucharest, Romania
来源：
JOURNAL OF NUCLEAR MEDICINE | 2015年 / 56卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1152
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The predictive value of pretherapy [68Ga]Ga-DOTA-TATE PET and biomarkers in [177Lu]Lu-PRRT tumor dosimetry
    Akhavanallaf, Azadeh
    Peterson, Avery B.
    Fitzpatrick, Kellen
    Roseland, Molly
    Wong, Ka Kit
    El-Naqa, Issam
    Zaidi, Habib
    Dewaraja, Yuni K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (10) : 2984 - 2996
  • [22] Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy
    Stenvall, Anna
    Gustafsson, Johan
    Larsson, Erik
    Roth, Daniel
    Sundlov, Anna
    Jonsson, Lena
    Hindorf, Cecilia
    Ohlsson, Tomas
    Gleisner, Katarina Sjogreen
    EJNMMI RESEARCH, 2022, 12 (01)
  • [23] Preliminary Clinical Investigation of [68Ga] Ga or [177Lu] Lu-Labeled DOTA-IBA for the Diagnosis and Treatment of Bone Metastasis
    Qi, Chi
    Chen, Yue
    Qiu, Lin
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [24] Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy
    Anna Stenvall
    Johan Gustafsson
    Erik Larsson
    Daniel Roth
    Anna Sundlöv
    Lena Jönsson
    Cecilia Hindorf
    Tomas Ohlsson
    Katarina Sjögreen Gleisner
    EJNMMI Research, 12
  • [25] Development of 68Ga/177Lu-LNC1011 for theranostics of prostate cancer
    Yang, Hongzhang
    Wen, Xuejun
    Guo, Huifeng
    Zhang, Jingjing
    Zhou, Zijian
    Chen, Xiaoyuan
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [26] RADIOLABELLING OF NEUROTENSIN AGONIST AND ANTAGONIST WITH 177Lu
    Lungu, V.
    Chiper, D.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 : S484 - S484
  • [27] RADIOLABELLING OF NEUROTENSIN AGONIST AND ANTAGONIST WITH 177LU
    Lungu, Valeria
    Chiper, Diana
    Matei, Lidia
    Barna, Catalina
    Gruia, Iuliana
    Tuta, Catalin
    Postolache, Cristian
    Cimpeanu, Catalina
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2010, 53 (5-6): : 466 - 468
  • [28] Preclinical imaging and radiotherapy of prostate cancer using the theranostic twins(68Ga/177Lu)-radiolabeled peptides
    Lim, J. C.
    Cho, E. H.
    Lee, S. Y.
    Dho, S. H.
    Kim, S. Y.
    Jung, S. H.
    RADIOTHERAPY AND ONCOLOGY, 2016, 118 : S67 - S68
  • [29] Does the Pretherapeutic Tumor SUV in 68Ga DOTATOC PET Predict the Absorbed Dose of 177Lu Octreotate?
    Ezziddin, Samer
    Lohmar, Jonas
    Yong-Hing, Charlotte J.
    Sabet, Amir
    Ahmadzadehfar, Hojjat
    Kukuk, Guido
    Biersack, Hans-Juergen
    Guhlke, Stefan
    Reichmann, Karl
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (06) : E141 - E147
  • [30] Theranostics of Metastatic Prostate Cancer Applying 64Cu/18F/68Ga PSMA PET-CT and 177Lu Radiopharmaceuticals
    Mirzaei, Siroos
    Mohammed, Fairoz
    Zandieh, Shahin
    CURRENT RADIOPHARMACEUTICALS, 2021, 14 (04) : 354 - 358
12345